The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation
Conditions: Systolic Heart Failure Stage D (Disorder); Mitral Regurgitation Intervention: Drug: evidence-based medications vs. high-dose hydralazine + evidence-based medications Sponsors: Kaohsiung Veterans General Hospital.; E-DA Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials